Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
Cartesian Therapeutics獲得FDA罕見兒童疾病認定,對於治療青少年皮肌炎的Descartes-08
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
Cartesian Therapeutics獲得FDA罕見兒童疾病認定,對於治療青少年皮肌炎的Descartes-08
譯文內容由第三人軟體翻譯。